The effect of anticonvulsant therapy on two doses of rocuronium-induced neuromuscular blockade

Journal of Neurosurgical Anesthesiology

Volumn 11, Issue 2, 1999, Pages 86-89

  Koenig, Heidi M ^a   Hoffman, William E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anticonvulsants; Arbamazepine; Neuromuscular blockade; Phenytoin; Rocuronium

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FENTANYL; ISOFLURANE; MIDAZOLAM; NITROUS OXIDE; PHENYTOIN; ROCURONIUM; THIOPENTAL;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

EID: 0032962985     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199904000-00003     Document Type: Article

References (14)

1. Alloul K, Whalley DG, Shutway F, Ebrahim Z, Varin F. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology 1996;84:330-9.
2. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
3. Koenig HM, Chowdhury P, Tsen L, Cunningham FE, Hoffman W. The effect of magnesium on vecuronium-induced paralysis in patients on anticonvulsant drugs. Anesthesiology 1995;83:A909.
4. Omstein E, Matteo R, Schwartz A, Silverberg P, Young W, Diaz J. The effect of phenytoin or the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987;67:191-6.
5. Platt PA, Thackray NM. Phenytoin-induced resistance to vecuronium. Anesth Intens Care 1993;21:185-91.
6. Roth S, Zeyd E. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 1987;66:691-3.
7. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990;71:665-9.
8. Alderdice MT, Trommer BA. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther 1980;215:92-6.
9. Gage PW, Lonergan M, Torda TA. Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction. Br J Pharmacol 1980;69:119-21.
10. Shaw PN, Houston JB, Rowland M, et al. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine. Br J Clin Pharmacol 1985;20:611-8.
11. Lekowski RL, Johnston JF. Clinical use of the Relaxograph NMT-100. Anesthesiol Rev 1994;21:22-6.
12. Schramm WM, Strasser K, Bartunek A, Gilly H, Spiss CK. Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients. Br J Anaesth 1996;77:607-11.
13. 2-sufentanil anesthesia. Anesth Analg 1994;78:318-21.
14. Gray HStJ, Slater RM, Pollard BJ. The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia 1989;44:379-81.